000 01340 a2200349 4500
005 20250515125258.0
264 0 _c20090202
008 200902s 0 0 eng d
022 _a0197-0186
024 7 _a10.1016/j.neuint.2008.06.005
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPákáski, Magdolna
245 0 0 _aInteractions between the amyloid and cholinergic mechanisms in Alzheimer's disease.
_h[electronic resource]
260 _bNeurochemistry international
_cNov 2008
300 _a103-11 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAcetylcholine
_xmetabolism
650 0 4 _aAlzheimer Disease
_xmetabolism
650 0 4 _aAmyloid beta-Peptides
_ximmunology
650 0 4 _aAnimals
650 0 4 _aCholine O-Acetyltransferase
_xmetabolism
650 0 4 _aCholinesterase Inhibitors
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aImmunotherapy
650 0 4 _aMuscarinic Agonists
_xtherapeutic use
650 0 4 _aNicotinic Agonists
_xtherapeutic use
650 0 4 _aReceptors, Cholinergic
_xphysiology
650 0 4 _aSynapses
_xmetabolism
700 1 _aKálmán, János
773 0 _tNeurochemistry international
_gvol. 53
_gno. 5
_gp. 103-11
856 4 0 _uhttps://doi.org/10.1016/j.neuint.2008.06.005
_zAvailable from publisher's website
999 _c18085280
_d18085280